Bayer has won U.S. approval for its planned takeover of Monsanto, a $62.5 billion deal that will create by far the largest seeds and pesticides maker.
A Bayer spokesman said the planned sale of businesses with 2.2 billion euros ($2.54 billion) in sales to BASF already agreed to address antitrust concerns, mainly in Europe, were not materially different from the DoJ’s demands.
“Receipt of the DOJ’s approval brings us close to our goal of creating a leading company in agriculture,” Bayer CEO Werner Baumann said in a statement.
Comments